Читать книгу Nanotechnology in Medicine - Группа авторов - Страница 30

The exploitation of microbial polymers for the design of novel therapeutic systems has evolved radically during the last decades, as they correspond to tunable, nontoxic, biodegradable, and biocompatible materials. Processing such materials in the form of nanofibers and nanoparticles is a very promising strategy that may provide more effective and convenient routes of administration, leading to sophisticated macromolecular materials for pharmaceutical and biomedical purposes. The applications of nanomaterials based on microbial polymers in biomedicine have become a large subject area, with original materials continuously being described in literature. As a consequence, commercial biomedical nanosystems based on exopolysaccharides (mainly pullulan and bacterial cellulose) and polyhydroxyalkanoates (mainly poly[hydroxybutyrate]), are expected to appear more frequently, as they may offer excellent prospects.